Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2005
05/26/2005WO2005047270A2 Substituted triazoles as sodium channel blockers
05/26/2005WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents
05/26/2005WO2005047251A1 Melanocortin receptor agonists
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005WO2005047247A1 Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005WO2005047246A1 Novel 1, 3-disubstituted azetidine deivatives for use as 5ht2a receptor ligands
05/26/2005WO2005046698A1 Fused heterocyclic compounds
05/26/2005WO2005046679A1 Immuno inhibitory pyrazolone compounds
05/26/2005WO2005046604A2 Heteroaryl-hydrazone compounds
05/26/2005WO2005019168A8 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
05/26/2005WO2004112719A8 Chemical compounds
05/26/2005WO2004046136A9 Pyrazine compounds as crf modulators
05/26/2005US20050113573 Such as 5-nitroso-2,4-di(1-pyrrolidinyl)-6-[4-(3-propionic acid methyl ester)piperazin-1-yl]pyrimidine and/or N-nitrosometoprolol for treating coronary heart disease, stroke, hemorrhagic shock, peripheral vascular disease, abdominal vascular insufficiency and transplant related surgery
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/26/2005US20050113439 Substituted pyrrole-indoles
05/26/2005US20050113438 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease
05/26/2005US20050113423 Modulators of ATP-binding cassette transporters
05/26/2005US20050113396 Na+/H++exchanger-3 (NHE-3) inhibitors; antiischemic agents
05/26/2005US20050113382 Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists
05/26/2005US20050113378 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
05/26/2005US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample
05/26/2005US20050113370 Therapeutic substituted indazole derivatives
05/26/2005US20050113369 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
05/26/2005US20050113361 Amide derivatives as NMDA receptor antagonists
05/26/2005US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
05/26/2005US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone
05/26/2005US20050113347 Novel antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
05/26/2005US20050113344 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
05/26/2005US20050113342 Novel imidazole derivatives and their use as pharmaceutical agents
05/26/2005US20050113341 Stent with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
05/26/2005US20050112490 Electrophotographic organophotoreceptors with novel charge transport compounds
05/26/2005US20050112487 electroconductive supports having layers containing azo compounds, charge transporting substance, acceptors and phenolic compounds, used in laser printer as well as high speed copiers
05/26/2005US20050112407 Organic electroluminescent device
05/26/2005US20050112406 Organometallic complexes and organic electroluminescence device using the same
05/26/2005CA2602772A1 Heterocyclic boronic acid compounds
05/26/2005CA2545384A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
05/26/2005CA2545373A1 Novel 1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005CA2545340A1 Fused heterocyclic compounds
05/26/2005CA2545259A1 Heteroaryl-hydrazone compounds
05/26/2005CA2545254A1 Substituted triazoles as sodium channel blockers
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005CA2534342A1 Amino acid prodrugs
05/25/2005EP1533294A1 Beta-alanine derivative and use thereof
05/25/2005EP1532980A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
05/25/2005EP1532209A2 Charge transport compositions and electronic devices made with such compositions
05/25/2005EP1532145A1 Pyrazole compositions useful as inhibitors of gsk-3
05/25/2005EP1532136A1 Pyridazine derivatives as ligands for gaba receptors
05/25/2005EP1532122A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
05/25/2005EP1532121A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
05/25/2005EP1532120A1 Phenylpyridazine derivatives as ligands for gaba receptors
05/25/2005EP1532119A2 Aryl substituted benzimidazoles and their use as sodium channel blockers
05/25/2005EP1532118A2 Imidazole compounds for the treatment of hepatitis c virus infections
05/25/2005EP1532117A1 Multi-substituded imidazolines and method of use thereof
05/25/2005EP1532109A1 Pyrrolidine derivatives as oxytocin antagonists
05/25/2005EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
05/25/2005EP1531819A1 USE OF I kappa B KINASE INHIBITORS FOR THE TREATMENT OF PAIN
05/25/2005EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
05/25/2005EP1531811A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
05/25/2005EP1531806A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions
05/25/2005EP1531674A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005EP1064281B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
05/25/2005DE10349587A1 Benzimidazolylderivate Benzimidazolylderivate
05/25/2005CN1620451A Benzhydryl derivatives
05/25/2005CN1620450A Quinazoline(di) ones for invertebrate pest control
05/25/2005CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
05/25/2005CN1620296A Substituted quinazoline derivatives as inhibitors of aurora kinases
05/25/2005CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use
05/25/2005CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors
05/25/2005CN1202819C Intraocular pressure reducing agent
05/24/2005US6897319 Therapeutic drugs for treating central nervous system disorders
05/24/2005US6897318 Process for making substituted pyrazoles
05/24/2005US6897232 Activate soluble guanylate cyclase; for use treating cardiovascular disorders, erectile dysfunction, diabetes, and cirrhosis of the liver, kidney disorders, and learning disability
05/24/2005US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents
05/24/2005US6897214 Quinazoline derivatives
05/24/2005US6897210 Anticancer agents; antiarthritic agents
05/24/2005US6897208 Protein kinase inhibitors
05/24/2005CA2157792C N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists
05/19/2005WO2005044923A1 Cyanine dye labelling reagents
05/19/2005WO2005044817A1 Modulators of cellular adhesion
05/19/2005WO2005044816A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
05/19/2005WO2005044807A2 Benzoimidazole compounds
05/19/2005WO2005044260A1 Use of crth2 antagonist compounds in therapy
05/19/2005WO2005044192A2 Triazole compounds and uses related thereto
05/19/2005WO2005044130A1 Pdk-1/akt signaling inhibitors
05/19/2005WO2003049678A3 Mitotic kinesin inhibitors
05/19/2005US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors
05/19/2005US20050107606 Process for producing optically active sulfoxide derivative
05/19/2005US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
05/19/2005US20050107456 such as N-(4-phenyl)-3-(4-chlorophenyl)-4-(4-cyanopyrazol-1-yl)-4,5-dihydro-1-pyrazolecarboxanilide, optionally mixed with extenders and/or surfactants, used for controlling pests
05/19/2005US20050107449 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
05/19/2005US20050107414 enzyme inhibitors such as N-(4-{4-[5-(2-Ethoxy-ethyl)-2,4,6-trioxo-hexahydro-pyrimidin-5-yloxy]-phenoxy}-benzyl)-acetamide, used for treating inflammation, cancers and other disorders
05/19/2005US20050107409 drugs such as 3-{[7-(2,5-dihydropyrrol-1-yl-carbonyl)-quinazolin-4-yl]aminomethyl}-4-hydroxy-benzamidine, used as anticoagulants
05/19/2005US20050107404 Mitotic kinesin inhibitors
05/19/2005US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions
05/19/2005US20050107399 Cytokine inhibitors
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 626